Physician profile
Vincent E Matteucci
NPI 1366532897
$1,908.20
in general payments reported to CMS, 2019-2025
17 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $240 · 2021: $46.03 · 2022: $63.49 · 2023: $255 · 2024: $507 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $449.22 | 2019-2025 | Clareon, Rocklatan |
| Abbvie INC. | $325.06 | 2022-2025 | |
| Biotissue Holdings INC. | $241.76 | 2024-2025 | |
| Ivantis, INC | $163.12 | 2020 | |
| Sun Pharmaceutical Industries INC. | $158.94 | 2020-2025 | Cequa |
| Apellis Pharmaceuticals, INC. | $103.75 | 2024 | Syfovre |
| Thea Pharma INC. | $85.79 | 2022-2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $74.49 | 2019 | |
| Novartis Pharmaceuticals Corporation | $67.43 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $53.41 | 2023-2025 | Miebo, Xiidra |
| Sight Sciences, INC. | $41.77 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Iridex Corporation | $27.60 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $26.12 | 2023 | Iolmaster 700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.51 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $15.40 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Matteucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.